 |
 |
||||||
 |
Commentaires de nos clients |
Votre panier
€0.00 (0 articles)
| |||||
- Pill for chest pains ‘could save 10,000 lives a year’
A pill for chest pains that costs around £10 per week could save the lives of thousands of heart failure patients.
- Low-carb and low-fat diets equally good for weight loss
Both low-fat and low-carb diets work equally well to help people lose weight over two years, new research has shown.
- Hope and controversy over prostate cancer screening
Screening older men with the PSA blood test could cut prostate cancer deaths by around half, according to a new study.
- Antidepressant use rises as recession feeds wave of worry
The number of antidepressants prescribed by the NHS has almost doubled in the last decade, and rose sharply last year as the recession bit, figures reveal.
- Overtime could break your heart
Overtime is bad for the heart, according to researchers who followed the careers of more than 6,000 Whitehall civil servants.
Notre page de facturation est certifiée par:
- BioDelivery Sciences to Present at Rodman & Renshaw, Baird, and Stifel ... - MarketWatch (press release)
BioDelivery Sciences to Present at Rodman & Renshaw, Baird, and Stifel .
- Optimal Antiemetic Therapy Remains Elusive for Pediatric Cancer Patients - Medscape
Optimal Antiemetic Therapy Remains Elusive for Pediatric Cancer PatientsMedscapeData from their analysis suggest that granisetron might be more effective at higher doses.
- Prostrakan goes into meltdown - Investors Chronicle
Prostrakan goes into meltdownInvestors ChronicleThe production problems with Sancuso, a granisetron patch to treat nausea in chemotherapy patients, were not given prominence at the half-year results in .
- A.P. Pharma Announces Second Quarter 2010 Financial Results - MarketWatch (press release)
A.
- BioDelivery Sciences Adds New Executive to Lead Business and Strategic Development - NCTechNews (press release)
BioDelivery Sciences Adds New Executive to Lead Business and Strategic DevelopmentNCTechNews (press release)Additional product candidates are being developed utilizing the BEMA technology for conditions such as nausea/vomiting (BEMA Granisetron) and migraine (BEMA .
|
| Copyright © indiapharmacyonline.com. Tous droits réservés. |